483 related articles for article (PubMed ID: 4213330)
41. Different serological examinations in cystic fibrosis patients: response to Pseudomonas aeruginosa St-Ag.
Magni A; Trancassini M; Giordano A; De Vito D; Cimino G; Quattrucci S; Antonelli M; Cipriani P
New Microbiol; 1997 Oct; 20(4):295-302. PubMed ID: 9385598
[TBL] [Abstract][Full Text] [Related]
42. Antibody response of rabbits and cystic fibrosis patients to an alginate-specific outer membrane protein of a mucoid strain of Pseudomonas aeruginosa.
Rehm BH; Grabert E; Hein J; Winkler UK
Microb Pathog; 1994 Jan; 16(1):43-51. PubMed ID: 8057826
[TBL] [Abstract][Full Text] [Related]
43. Pseudomonas aeruginosa infection and humoral antibody response of patients with cystic fibrosis.
Neter E
J Infect Dis; 1974 Nov; 130 Suppl(0):S132-3. PubMed ID: 4213765
[No Abstract] [Full Text] [Related]
44. Pseudomonas agglutinins in patients with cystic fibrosis.
Habboushe C; Iacocca V; Braddock L; Barbero G
Pediatrics; 1971 Dec; 48(6):973-4. PubMed ID: 5001974
[No Abstract] [Full Text] [Related]
45. Host inflammatory responses to first isolation of Pseudomonas aeruginosa from sputum in cystic fibrosis.
Elborn JS; Cordon SM; Shale DJ
Pediatr Pulmonol; 1993 May; 15(5):287-91. PubMed ID: 8327287
[TBL] [Abstract][Full Text] [Related]
46. Nonspecific immunoglobulin synthesis and elevated IgG levels in rabbits immunized with mucoid exopolysaccharide from cystic fibrosis isolates of Pseudomonas aeruginosa.
Pier GB; Elcock ME
J Immunol; 1984 Aug; 133(2):734-9. PubMed ID: 6234359
[TBL] [Abstract][Full Text] [Related]
47. [Slime from a mucoid strain of Pseudomonas aeruginosa in mucoviscidosis and other respiratory diseases (author's transl)].
Marty N; Lapchine L; Pradere J; Dutau G
Ann Pediatr (Paris); 1981 Apr; 28(4):261-5. PubMed ID: 6784657
[No Abstract] [Full Text] [Related]
48. Distribution of antibodies to selected antigens of Pseudomonas aeruginosa in children and young adults with cystic fibrosis.
Gaweł J; Pogorzelski A; Działek-Smętek E; Sochań B; Ligarska R; Lącka M; Mazurek H
Pneumonol Alergol Pol; 2014; 82(4):336-41. PubMed ID: 24964236
[TBL] [Abstract][Full Text] [Related]
49. The approach to Pseudomonas aeruginosa in cystic fibrosis.
Bendiak GN; Ratjen F
Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546
[TBL] [Abstract][Full Text] [Related]
50. The serology of Pseudomonas aeruginosa analysed by means of quantitative immunoelectrophoretic methods. II. Comparison of the antibody response in man against thirteen O groups of Ps. aeruginosa.
Hoiby N
Acta Pathol Microbiol Scand B; 1975 Aug; 83(4):328-34. PubMed ID: 808100
[TBL] [Abstract][Full Text] [Related]
51. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
Hansen CR; Pressler T; Høiby N
J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
[TBL] [Abstract][Full Text] [Related]
52. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.
Burns JL; Gibson RL; McNamara S; Yim D; Emerson J; Rosenfeld M; Hiatt P; McCoy K; Castile R; Smith AL; Ramsey BW
J Infect Dis; 2001 Feb; 183(3):444-52. PubMed ID: 11133376
[TBL] [Abstract][Full Text] [Related]
53. Serum antibodies to Pseudomonas aeruginosa outer-membrane proteins and iron-regulated membrane proteins at different stages of chronic cystic fibrosis lung infection.
Shand GH; Pedersen SS; Brown MR; Høiby N
J Med Microbiol; 1991 Apr; 34(4):203-12. PubMed ID: 1902261
[TBL] [Abstract][Full Text] [Related]
54. Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis.
Döring G; Høiby N
Infect Immun; 1983 Oct; 42(1):197-201. PubMed ID: 6413411
[TBL] [Abstract][Full Text] [Related]
55. Quantitative studies on immunologically specific and non-specific absorption of Pseudomonas aeruginosa antibodies in serum from cystic fibrosis patients.
Høiby N; Hertz JB
Acta Pathol Microbiol Scand C; 1981 Jun; 89(3):185-92. PubMed ID: 6797245
[TBL] [Abstract][Full Text] [Related]
56. Detection of Pseudomonas aeruginosa in patients with cystic fibrosis.
Tramper-Stranders GA; van der Ent CK; Wolfs TF
J Cyst Fibros; 2005 Aug; 4 Suppl 2():37-43. PubMed ID: 15961356
[TBL] [Abstract][Full Text] [Related]
57. Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success?--A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection.
Johansen HK; Nørregaard L; Gøtzsche PC; Pressler T; Koch C; Høiby N
Pediatr Pulmonol; 2004 May; 37(5):427-32. PubMed ID: 15095326
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of specific immune response in early P. aeruginosa infection in cystic fibrosis patients.
Dolce D; Cariani L; Campana S; Ravenni N; Mergni G; Biffi A; Colombo C; Gagliardini R; Cirilli N; Manso E; Padoan R; Soncini E; Forte FR; D'Aprile A; Ratclif L; Amboni M; Casciaro R; Minicucci L; Borio T; Cosimi A; Vieni G; Zinnarello C; Fiscarelli E; Collura M; Pensabene T; Braggion C; Döring G; Taccetti G
J Cyst Fibros; 2014 Jan; 13(1):116-7. PubMed ID: 24022018
[No Abstract] [Full Text] [Related]
59. Mucoid Escherichia coli in cystic fibrosis.
Macone AB; Pier GB; Pennington JE; Matthews WJ; Goldmann DA
N Engl J Med; 1981 Jun; 304(24):1445-9. PubMed ID: 6785645
[TBL] [Abstract][Full Text] [Related]
60. Prognostic implications of circulating immune complexes and Pseudomonas aeruginosa-specific antibodies in cystic fibrosis.
Dasgupta MK; Lam J; Döring G; Harley FL; Zuberbuhler P; Lam K; Reichert A; Costerton JW; Dossetor JB
J Clin Lab Immunol; 1987 May; 23(1):25-30. PubMed ID: 3112403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
